Literature DB >> 28160105

Endoscopic Radiofrequency Ablation of the Pancreas.

Tarun Rustagi1, Ankit Chhoda2.   

Abstract

Radiofrequency ablation (RFA) is a well-established technique to ablate dysplastic and neoplastic tissue via local thermal coagulative necrosis. Despite the widespread use in management of several cancers, the application of RFA in pancreas has been limited due to the increased risks of complications from the increased sensitivity of pancreatic tissue to thermal injury and proximity to vascular and biliary structures. RFA has been successfully used during laparotomy for locally advanced pancreatic carcinoma but requires an invasive approach. Endoscopic ultrasound-guided RFA offers the best combination of excellent visualization, real-time imaging guidance, and precise localization with minimal invasiveness. Several animal and human studies have demonstrated the technical feasibility and safety of endoscopic RFA in the pancreas. This article provides a comprehensive review of endoscopic RFA in the management of pancreatic lesions.

Entities:  

Keywords:  CTP; Cryotherm; EUS; Endoscopic ultrasound; Habib; Insulinoma; Pancreatic cancer; Pancreatic cystic lesion; Pancreatic cysts; RFA

Mesh:

Year:  2017        PMID: 28160105     DOI: 10.1007/s10620-017-4452-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  50 in total

1.  Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer.

Authors:  Yi-Ping Zou; Wei-Min Li; Fang Zheng; Fu-Cheng Li; Hui Huang; Ji-Dong Du; Hao-Run Liu
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  Radiofrequency ablation in pancreatic cancer.

Authors:  P Hadjicostas; N Malakounides; C Varianos; E Kitiris; F Lerni; P Symeonides
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  Short term chemotherapy followed by radiofrequency ablation in stage III pancreatic cancer: results from a single center.

Authors:  Isabella Frigerio; Roberto Girelli; Alessandro Giardino; Paolo Regi; Roberto Salvia; Claudio Bassi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-08       Impact factor: 7.027

4.  Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma.

Authors:  Yi-You Chiou; Jen-I Hwang; Yi-Hong Chou; Hsin-Kai Wang; Jen-Huey Chiang; Cheng-Yen Chang
Journal:  Kaohsiung J Med Sci       Date:  2005-07       Impact factor: 2.744

5.  EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos).

Authors:  Sundeep Lakhtakia; Mohan Ramchandani; Domenico Galasso; Rajesh Gupta; Sushma Venugopal; Rakesh Kalpala; D Nageshwar Reddy
Journal:  Gastrointest Endosc       Date:  2015-09-21       Impact factor: 9.427

Review 6.  Intraductal radiofrequency ablation for management of malignant biliary obstruction.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Dig Dis Sci       Date:  2014-06-07       Impact factor: 3.199

7.  Endoscopic treatment of malignant biliary strictures.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Curr Gastroenterol Rep       Date:  2015-01

8.  Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience.

Authors:  Gianpaolo Carrafiello; Domenico Laganà; Elisa Cotta; Monica Mangini; Federico Fontana; Francesca Bandiera; Carlo Fugazzola
Journal:  Cardiovasc Intervent Radiol       Date:  2010-04-22       Impact factor: 2.740

9.  Radiofrequency ablation as a treatment for hilar cholangiocarcinoma.

Authors:  Wei-Jun Fan; Pei-Hong Wu; Liang Zhang; Jin-Hua Huang; Fu-Jun Zhang; Yang-Kui Gu; Ming Zhao; Xiang-Long Huang; Chang-Yu Guo
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

10.  Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer.

Authors:  Tae Jun Song; Dong Wan Seo; Sundeep Lakhtakia; Nageshwar Reddy; Dong Wook Oh; Do Hyun Park; Sang Soo Lee; Sung Koo Lee; Myung-Hwan Kim
Journal:  Gastrointest Endosc       Date:  2015-09-04       Impact factor: 9.427

View more
  11 in total

Review 1.  Non-surgical ablative therapies for inoperable benign insulinoma.

Authors:  C Mele; A Brunani; B Damascelli; V Tichà; L Castello; G Aimaretti; M Scacchi; P Marzullo
Journal:  J Endocrinol Invest       Date:  2017-07-28       Impact factor: 4.256

2.  Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.

Authors:  Yazan Fahmawi; Ansh Mehta; Haneen Abdalhadi; Lindsey Merritt; Meir Mizrahi
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 3.  EUS-RFA of the pancreas: where are we and future directions.

Authors:  Lakshmi Asritha Gollapudi; Amy Tyberg
Journal:  Transl Gastroenterol Hepatol       Date:  2022-04-25

4.  Novel swine biliary dilatation model with temperature-controlled endobiliary radiofrequency ablation: An effective tool for training in EUS-guided biliary drainage.

Authors:  Dongwook Oh; Dario Ligresti; Dong-Wan Seo
Journal:  Endosc Ultrasound       Date:  2020 Jul-Aug       Impact factor: 5.628

5.  Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy.

Authors:  Louis Buscail; Adrian Culetto; Fatima-Zhora Mokhrane; Bertrand Napoléon; Olivier Meyrignac; Baptiste Molinier; Marine Lebrin; Barbara Bournet; Emilie Bérard; Cindy Canivet
Journal:  Endosc Int Open       Date:  2022-06-10

6.  EUS-guided radiofrequency ablation: Where we are?

Authors:  Hussein Hassan Okasha; Yehia M Naga; Mohammad El Sherbiny
Journal:  Endosc Ultrasound       Date:  2020 Sep-Oct       Impact factor: 5.628

7.  Novel EUS-guided microwave ablation of an unresectable pancreatic neuroendocrine tumor.

Authors:  Carlos Robles-Medranda; Martha Arevalo-Mora; Roberto Oleas; Juan Alcivar-Vasquez; Raquel Del Valle
Journal:  VideoGIE       Date:  2022-01-19

8.  Case Report: Insulinoma Co-Existing With Type 2 Diabetes - Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation.

Authors:  Johnny Yau-Cheung Chang; Chariene Shao-Lin Woo; David Tak-Wai Lui; Matrix Man-Him Fung; Alan Chun-Hong Lee; Eunice Ka-Hong Leung; Yu-Cho Woo; Wing-Sun Chow; Karen Siu-Ling Lam; Kathryn Choon-Beng Tan; Chi-Ho Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

9.  EUS-guided pancreatic radiofrequency ablation: preclinical comparison of two currently available devices in a pig model.

Authors:  Maximilien Barret; Sarah Leblanc; Alexandre Rouquette; Stanislas Chaussade; Benoit Terris; Frédéric Prat
Journal:  Endosc Int Open       Date:  2019-01-17

10.  Possible involvement of HSP70 in pancreatic cancer cell proliferation after heat exposure and impact on RFA postoperative patient prognosis.

Authors:  Hui-Bin Song
Journal:  Biochem Biophys Rep       Date:  2019-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.